Wenyu Wu

Department of Nuclear Medicine, Nanjing Medical University

Affiliated withNanjing Medical University Nanjing Medical University

Research Area

Cancer Research

Biography

Wenyu Wu has not added Biography.
If you are Wenyu Wu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 6	2023

Other Publications

Article	Year
A new and efficient synthesis of 6-O-methylscutellarein, the major metabolite of the natural medicine scutellarin. Molecules (Basel, Switzerland)\| PubMed ID: 26042857	2015
An Efficient Chemical Synthesis of Scutellarein: An in Vivo Metabolite of Scutellarin. Molecules (Basel, Switzerland)\| PubMed ID: 26927039	2016
Development and Structural Modification of BACE1 Inhibitors. Molecules (Basel, Switzerland)\| PubMed ID: 28025519	2016
Synthesis and Bioactivity Characterization of Scutellarein Sulfonated Derivative. Molecules (Basel, Switzerland)\| PubMed ID: 28635646	2017
A novel and efficient synthesis of phenanthrene derivatives via palladium/norbornadiene-catalyzed domino one-pot reaction. Beilstein journal of organic chemistry\| PubMed ID: 30800179	2019
[Ga]Ga-NOTA-MAL-Cys-exendin-4, a potential GLP-1R targeted PET tracer for the detection of insulinoma. Nuclear medicine and biology\| PubMed ID: 31450071	2019
Design, synthesis and evaluation of 2-amino-imidazol-4-one derivatives as potent β-site amyloid precursor protein cleaving enzyme 1 (BACE-1) inhibitors. Bioorganic & medicinal chemistry letters\| PubMed ID: 31711785	2019
Total synthesis, chemical modification and structure-activity relationship of bufadienolides. European journal of medicinal chemistry\| PubMed ID: 31945667	2020
Safety and tolerability of Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in-human use. European journal of nuclear medicine and molecular imaging\| PubMed ID: 33006657	2021
Use of Chromogranin A for Monitoring Patients With Pancreatic Neuroendocrine Neoplasms. Pancreas\| PubMed ID: 34347728	2021
Smart I-Labeled Self-Illuminating Photosensitizers for Deep Tumor Therapy. Angewandte Chemie (International ed. in English)\| PubMed ID: 34374188	2021
An efficient strategy for digging protein-protein interactions for rational drug design - A case study with HIF-1α/VHL. European journal of medicinal chemistry\| PubMed ID: 34638033	2022
LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis. Clinical and translational medicine\| PubMed ID: 35083881	2022
Ga-DOTA-NT-20.3 Neurotensin Receptor 1 PET Imaging as a Surrogate for Neuroendocrine Differentiation of Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine\| PubMed ID: 35177423	2022
Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East Asians. Frontiers in oncology\| PubMed ID: 35402274	2022
Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors. Acta pharmaceutica Sinica. B\| PubMed ID: 35530129	2022
Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC). Endocrine\| PubMed ID: 35767182	2022
Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer. Frontiers in oncology\| PubMed ID: 35924153	2022
Development and validation of Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer. EJNMMI research\| PubMed ID: 36175753	2022